Does Insurance Cover Sublingual Immunotherapy?

Usually yes, with conditions. The four FDA-approved sublingual tablets — Grastek, Oralair, Ragwitek, and Odactra — are prescription pharmacy drugs with approved indications, so most commercial insurance plans cover them, typically after prior authorization to confirm medical necessity. Medicare Part D may cover them as well, depending on your plan's formulary. Your out-of-pocket cost is then a pharmacy copay, which manufacturer copay-assistance cards can sometimes reduce further. The main limitation is clinical rather than financial: each tablet treats only one allergen, so if you are sensitized to multiple triggers, a single tablet may not address all of your symptoms. Confirm formulary placement and prior-authorization requirements with your specific plan before starting.

Generally no. Compounded multi-allergen liquid drops are used off-label and are not FDA-approved, and insurers — including commercial plans, Medicare, and Medicaid — routinely exclude off-label treatments from coverage. This is consistent across payers because it reflects the product's regulatory status rather than any single plan's policy. As a result, most patients pay for liquid drops out of pocket, commonly around $99 per month through a telehealth subscription. The drops are, however, HSA- and FSA-eligible when prescribed, so you can pay with pre-tax dollars and reduce the effective cost. Related services like testing and consults may still run through your medical benefits even when the drops do not.

The difference is regulatory and it drives everything. Tablets have gone through the FDA approval process and carry approved indications, so they are treated like any other prescription drug and are usually covered. Compounded liquid drops have not been FDA-approved for sublingual use and are considered off-label, which is the standard trigger for insurance exclusion. Clinically, tablets cover one allergen each while drops can be customized to several, so the more convenient coverage path sometimes does not match the better clinical fit. The practical takeaway: if a single approved tablet matches your dominant allergen, that route is usually cheaper after coverage; if you need multi-allergen treatment, drops are typically self-pay.

It depends on the form. Medicare Part B covers traditional in-office allergy shots but does not cover liquid sublingual drops, which are off-label. FDA-approved SLIT tablets may be covered under Medicare Part D as prescription drugs, subject to your plan's formulary and any prior-authorization or step-therapy requirements. Compounded multi-allergen liquid drops are generally not covered under any part of Medicare. If you are on Medicare and want sublingual treatment, the most likely covered path is an approved tablet that matches your allergen; otherwise, expect to pay for compounded drops out of pocket, which you can do with HSA funds if you have an eligible account.

Start by clarifying which form your treatment uses, because that determines the question you should ask. For an FDA-approved tablet, call your insurer's pharmacy benefit line and ask whether the specific drug is on the formulary and what prior-authorization or step-therapy rules apply. For compounded liquid drops, ask your medical benefit line directly whether off-label sublingual immunotherapy is covered; the answer is usually no. Either way, ask separately about allergy testing and specialist visits, since those are often covered even when the medication is not. Request everything in writing or note the reference number, and confirm whether your HSA or FSA can be applied.